Ventricular Assist Devices Market Report in PPT: Top Companies, Trends and Future Details for Business Opportunity

1
Global Ventricular Assist Devices Market Research
and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
GLOBAL Ventricular Assist Market Research
Report According to the latest report by IMARC
Group, titled Ventricular Assist Devices Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2021-2026, the global
ventricular assist devices market size reached a
strong growth in 2020. Also known as a
mechanical circulatory support device, a
ventricular assist device (VAD) is an implantable
mechanical pump utilized to support heart
function and blood flow among patients with a
weak heart or those suffering from heart failure.
It is implanted as short-term treatment after
surgery or while patients are waiting for a heart
transplant. It assists in pumping blood from the
lower chambers of the heart to the rest of the
body. It generally includes tubes, an electronic
controller and a power source. It is employed
in destination therapies, bridge-to-transplant
(BTT), bridge-to-recovery (BTR) and
bridge-to-candidacy (BTC). Request Free Sample
Report https//www.imarcgroup.com/ventricular-ass
ist-devices-market/requestsample
4
Report Description and Highlights
Report Description
Global Ventricular Assist Market Trends Heart
transplantation is an optimal surgical therapy
utilized for end?stage heart failure (HF). It is
increasingly becoming limited on account of the
shortage of suitable heart donors and the
widening gap between donors and recipients. This
represents one of the significant factors
propelling the global ventricular assist devices
market growth. Apart from this, the rising
prevalence of cardiovascular disorders (CVDs),
such as hypertension, ventricular septal defect,
heart failure and stroke, due to stressful and
sedentary lifestyles and increasing consumption
of fast food, is also strengthening the market
growth. Furthermore, the leading manufacturers
are using advanced technologies to develop
miniature devices designed with infection
control, which is anticipated to impel the market
growth in the coming years. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
•  Breakup By Product Type
• Left ventricular assist device
• Right ventricular assist device
• Biventricular assist device
• Breakup by Flow Type
• Pulsatile
• Non-pulsatile
• Continuous flow
• Breakup By Application
• Bridge-to-transplant (BTT) therapy
• Destination therapy
• Bridge to recovery and bridge to candidacy

6
Report Description and Highlights
Report Description

• Breakup by end-user
• Ambulatory surgery centers
• Hospitals and others
•  Breakup By Region
• Europe
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
• Note We are updating our research report
  2021-2026. If you want to need latest primary and
  secondary data with Cost Module, Business
  Strategy, Distribution Channel, etc.

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Player
• Abbott Laboratories (ABT)
• Abiomed
• Berlin Heart GmbH (Syscore GmbH)
• BiVACOR, Inc
• Calon Cardio Technology Limited
• Cardiacassist Inc. (LivaNova PLC)
• CHF Solutions
• Jarvik Heart
• MAQUET GmbH (Getinge Group)
• Medtronic Plc
• Syncardia Systems LLC
• TandemLife (LivaNova Plc) and Terumo Corporation
•  
• View Full Customization Report with TOC and List
  of figure https//www.imarcgroup.com/ventricular
  -assist-devices-market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us